Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 22,838 | 5,710 | 24,927 | 23,450 | 13,812 |
| Cost of Goods | 4,117 | 3,617 | 2,612 | 789 | 1,722 |
| Gross Profit | 18,721 | 5,710 | 22,315 | 22,661 | 12,090 |
| Operating Expenses | 35,627 | 35,732 | 32,102 | 29,532 | 24,267 |
| Operating Income | -16,789 | 5,710 | -9,175 | -6,082 | -11,455 |
| Interest Expense | 2,335 | 2,957 | 3,608 | 4,022 | 2,824 |
| Other Income | 9,857 | 2,957 | 5,747 | 8,779 | 4,499 |
| Pre-tax Income | -9,267 | 5,710 | -7,036 | -1,325 | -9,780 |
| Income Tax | 26 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -9,293 | 5,710 | -7,036 | -1,325 | -9,780 |
| Net Income | $-9,293 | $5,710 | $-7,036 | $-1,325 | $-9,780 |
| EPS Basic Total Ops | -0.10 | -0.11 | -0.08 | -0.02 | -0.13 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.08 | -0.02 | -0.13 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -0.08 | -0.02 | -0.13 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.08 | -0.02 | -0.13 |
| EBITDA(a) | $-15,946 | $-32,301 | $-6,365 | $-2,366 | $-8,920 |